Baxter International Inc - Jun 24, 2021 Form 4 Insider Report for Miromatrix Medical Inc. (MIRO)

Role
10%+ Owner
Signature
/s/ Ellen K. Bradford, Senior Vice President & Corporate Secretary
Stock symbol
MIRO
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 05:26 PM
Previous filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRO Common Stock Conversion of derivative security +2.08M 2.08M Jun 24, 2021 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRO Series C Convertible Preferred Stock Conversion of derivative security -2.08M -100% 0 Jun 24, 2021 Common Stock 2.08M See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series C Convertible Preferred Stock of Miromatrix Medical Inc. (the "Issuer") were automatically converted into 2,083,333 shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), immediately prior to the closing of the Issuer's initial public offering (the "IPO") of its Common Stock, without payment of consideration. The 2,083,333 shares amount is based on the actual IPO price of $9.00 per share of Common Stock. The 2,343,750 shares amount previously reported on Form 3, dated 06/23/2021, was based on an assumed IPO price of $8.00 per share of Common Stock.
F2 The reported securities are owned directly by Baxter Healthcare Corporation, a wholly owned subsidiary of Baxter International Inc.